Nucleate Boston

We are excited to announce our partnership with Portal Innovations, LLC! This is a lab-space award partnership, and we invite all startups in our network to apply for Portal Innovation’s Pioneer Award. Award Details & Eligibility: 🔹 Lab Access: 12 months of complimentary lab space at Portal’s Southline Boston facility (1 bench) 🔹 Eligibility: Open to Nucleate Activator teams (current and alumni), applicants must be ready to activate the award within 12 months of acceptance 🔹 Selection Process: Semi-finalists will be selected to participate in a pitch competition at Portal Southline Boston (date TBD) where the final award will be selected by a panel of judges Apply Here: https://lnkd.in/ebbJ9hNM   Portal Innovations, LLC is a leading life sciences global venture development engine, bridging the gap between scientific exploration and entrepreneurial realization. Portal equips early-stage life sciences companies with the seed capital, cutting-edge wet lab space, and seasoned management expertise necessary for them to flourish. Portal’s market-based approach identifies the most promising life science startups and supports them throughout their journey. Portal engages deeply in every aspect of the business, leveraging their network to tackle each company’s specific challenges and lead startups to successful Series A investments with world-class VCs and strategic investors. To date, Portal has lab space in four U.S. markets, with Portal Boston at Southline being their largest facility, standing at 58,000 SF of space in the former Boston Globe building. We thank Portal Innovations, LLC for their support of Nucleate Boston and this year’s Activator Cohort. With their contribution we will continue to democratize biotechnology and enable new company formation in Boston and beyond!

🌟 We are excited to announce the selection of 18 incredible teams for our 2025 Activator cohort 🌟 These teams represent institutions including Tufts University, Northeastern University, Boston University, Harvard University, Massachusetts Institute of Technology, and Brown University, with several teams comprising inter-university collaborations. The cohort is also diverse in the technologies showcased, from diagnostics and therapeutics to R&D tools and green technology. We can’t wait to see the potential of these teams unfold over the next few months as they participate in the Activator and utilize all the tools that Nucleate has to offer. Last Thursday, the cohort convened to hear from a panel of past cohort alumni, including John Vroom (Kano Therapeutics), Andrew Thomson (Modulate Bio) and Fang Xie (Dotilix Pharmaceuticals). Many thanks to them for their insights, to Lab Central for hosting and Jake Rossetto for moderating! If you are interested in sponsoring a team or a 2025 Activator workshop, please reach out to boston@nucleate.org. For further announcements on the progress of this year’s cohort, stay tuned to our LinkedIn as well as our newsletter: https://lnkd.in/esDEYXrt #bostonbiotech #nucleate #innovation

Join us this Wednesday, February 12th, for the Next Inside Business Development Seminar! This seminar will focus on developing your commercialization strategy and the key factors to consider during the early-stage company formation process. We’re excited to feature two accomplished entrepreneurs: ▫️ Erwin Estigarribia, CEO of Headlamp Health ▫️ Celina Burns, Co-founder & CEO of Unifyed Health They’ll share firsthand insights on successfully launching and scaling companies in a moderated Q&A, followed by an open floor discussion where you can ask your burning questions. Don't miss this opportunity to learn from industry leaders and connect with like-minded professionals! RSVP here: https://lu.ma/5cd9xlsi

Join us for a pivotal conversation on the future of aging therapeutics! On March 3, 2025, we’re continuing Nucleate: Inside Aging with an insightful virtual session featuring leaders in aging biology and therapeutics: 🎙 Nir Barzilai, MD Founder and Director, Institute for Aging Research 🎙 Joan Mannick, MD CEO & Co-Founder, Tornado Therapeutics 🎙 Matt Kaeberlein, Ph.D. CEO, Optispan, Inc. These renowned experts will share their vision on the path from aging therapeutics research to clinical applications and how you can get involved in the field’s groundbreaking work. This is a must-attend event for: ▫️ Researchers and students passionate about aging therapeutics. ▫️ Investors exploring innovative aging biotech. ▫️Anyone eager to understand how science is transforming aging and health. 💡 Don’t miss out—register today: https://lnkd.in/gbfend-E 💡 1pm ET Let’s innovate and shape the future of aging therapeutics together! #AgingTherapeutics #AgingBiology #Longevity #NucleateInsideAging #Innovation #Biotechnology #VirtualEvent

Announcing Encode: AI for Science 🧬 We're launching a fellowship powered by Advanced Research + Invention Agency (ARIA) to connect top AI talent with leading UK science labs to unlock the next wave of scientific breakthroughs. https://encode.pillar.vc Spend one year embedded in top science labs in ARIA's Opportunity Spaces across the UK. Access mentorship from leaders who have built to scale and join a thriving community shaping AI for Science. ----- AI is already profoundly reshaping society, but we believe there is an even bigger revolution underway: the acceleration of scientific discovery.  The potential of AI for science will dwarf everything we've seen so far. We meet amazing AI/ML people that want to work on science – new medicines, new materials, new physics etc. But there's a problem: science often starts in academia, and it's hard to contribute without being on a traditional academic track, and without resources to scale. Encode will provide industry-level compensation, robust compute resources, a community of the most ambitious scientists, founders, and leaders in AI for Science. …with resources to scale discoveries into new companies and organizations, supported by amazing advisors: Rohit Prasad, Andrew Giessel, Amy Villeneuve, Samuel G. Rodriques, Simon Kohl, Miriam Huntley, Debora Marks, Theofanis Karaletsos, Leonard Wossnig, Joshua Goldford, Steve Crossan, Zachary Lipton, Megan Stanley, Jacomo Corbo We’ve begun crafting projects with three academic launch partners: - Molly Stevens DBE(Oxford), Biomaterials Design - Philip Stier (Oxford), Climate Systems - Riccardo Sapienza & Jack Gartside (Imperial), Neuromorphic Computing with more info coming soon + more projects to be announced! Get in touch with us if you: - are an academic interested in partnering with Encode - are interested in becoming an Encode fellow - want to get involved in any other way! https://lnkd.in/eDfhbbmn Apply as an academic partner now to host a fellow. Applications for fellows will open March 20th.

We’re thrilled to announce that Lybra has begun operations at LabCentral, following our selection as an #IgniteGoldenTicket recipient. We’re excited to join the community and continue developing our platforms for the treatment of autoimmune skin diseases.

We’re thrilled to announce that Lybra has begun operations at LabCentral, following our selection as an #IgniteGoldenTicket recipient. We’re excited to join the community and continue developing our platforms for the treatment of autoimmune skin diseases.

Grow with us! We’re looking for researchers and engineers eager to apply AI, machine learning, and other software tools to unlock solutions in plant science that support the planet. If your passion and expertise lie at the intersection of these fields, we’d love to hear from you. Research Fellow, AI & ML (4–6 months) Apply AI and ML to advance plant cell culture R&D, working on predictive modeling, data analysis, and experimental optimization. Ideal for later stage Master’s/PhD students, recent grads, or postdocs. Apply: https://lnkd.in/gvB7wQ-a Software Engineering Intern (Summer 2025) Develop computational tools, automation, and data visualization to support plant research. Great for undergrad/grad students in CS, Software Eng., or related fields. Apply: https://lnkd.in/gzwRaPca Know someone who’d be a great fit? Tag them or share this post! #Hiring #AI #MachineLearning #SoftwareEngineering #PlantCellCulture

🚀 Revolutionizing Gene Therapy with AI-Powered Capsid Engineering What happens when you combine physics, systems biology, and machine learning to tackle one of the biggest challenges in gene therapy? You get Dyno Therapeutics—a company pioneering AI-driven capsid engineering to improve gene delivery and make therapies more effective and accessible. In this latest episode with Sam Kessel MD, MBA, Eric Kelsic, CEO and co-founder of Dyno, shares his journey: 🔬 How his physics and systems biology background shaped his approach to solving biological problems 🧬 Lessons learned from working in George Church’s lab at Harvard 🤖 How Dyno uses machine learning to engineer better AAV capsids 🤝 Using the scientific method to approach business development Kelsic’s story is a masterclass in identifying high-impact problems, leveraging cutting-edge technology, and translating scientific insights into therapeutics to improve patient’s lives. Check out the full episode to dive into the future of AI-powered gene therapy! 🎧👇 https://lnkd.in/gt6TDTZY #GeneTherapy #AI #Biotech #Innovation #MachineLearning